Donahue J, Gilpin E, Lee T H, Busch M P, Croft M, Carrier E
Department of Medicine, University of California San Diego School of Medicine, La Jolla, USA.
Transplantation. 2001 Feb 15;71(3):359-68. doi: 10.1097/00007890-200102150-00004.
To date, over 40 in utero transplants have been performed in humans; the only successes were documented in the treatment of severe combined immunodeficiency syndromes. Hemoglobinopathies and metabolic disorders are candidate diseases for this approach; however, when applied clinically, the results have been discouraging. To address the role of the fetal immune system in the outcome of in utero transplantation, we have developed a murine model of in utero transplantation in immunologically intact murine recipients and have studied chimerism and tolerance/immunity to allogeneic donor cells through the lives of the animals.
We have performed experiments in which purified murine sca-1+/lin- cells and c-kit+/lin- cells of C57BL/6 (H2b) mice were injected into Balb/c (H2d) fetal recipients at early gestational ages. Chimerism was tested by highly sensitive semiquantitative polymerase chain reaction assay and tolerance/immunity to donor cells was studied by in vivo (skin grafts, responses to postnatal boosts) and in vitro (mixed lymphocyte culture, cytotoxicity, and cytokine release) assays.
One hundred percent (10/10) of mice transplanted with c-kit+ cells and 44% (4/9) of mice transplanted with sca+ cells showed circulating donor cells within the first 6 months of life (P=0.031). Mice in the sca+ group rejected donor skin grafts at a mean time of 9.1+/-0.2 days, whereas mice in the c-kit+ group rejected donor skin grafts at a mean time of 15.1+/-0.7 days (P=0.001). The difference between the transplanted groups and non-transplanted controls was also significant (P<0.05). All mice transplanted with sca+/lin- cells showed greater response to donor cells than to third-party cells at all effector to target ratios (P=0.002). Differences in response to donor alloantigen between sca+ and c-kit+ groups were significant (P=0.003). Cytokine quantification demonstrated higher TH1 than TH2 cytokine release in all groups, and the response to donor cells was higher in the sca+ compared with c-kit+ mice (P=0.031).
These results demonstrate a low level of chimerism and tolerance in mice transplanted in utero with sca+/lin- and c-kit+/lin- cells. The possibility of active in utero immunization to donor cells is supported by accelerated skin graft rejection in mice transplanted with sca+ cells and enhanced in vitro immune responses in mice with persistent microchimerism.
迄今为止,已在人体中进行了40多例子宫内移植;仅在重症联合免疫缺陷综合征的治疗中有成功记录。血红蛋白病和代谢紊乱是这种治疗方法的候选疾病;然而,临床应用时结果并不理想。为了探讨胎儿免疫系统在子宫内移植结局中的作用,我们建立了一个在免疫功能正常的小鼠受体中进行子宫内移植的小鼠模型,并在动物的整个生命过程中研究了嵌合体以及对同种异体供体细胞的耐受性/免疫性。
我们进行了实验,将C57BL/6(H2b)小鼠纯化的sca-1+/lin-细胞和c-kit+/lin-细胞在妊娠早期注射到Balb/c(H2d)胎儿受体中。通过高灵敏度半定量聚合酶链反应分析检测嵌合体,并通过体内(皮肤移植、对出生后增强刺激的反应)和体外(混合淋巴细胞培养、细胞毒性和细胞因子释放)分析研究对供体细胞的耐受性/免疫性。
移植c-kit+细胞的小鼠中有100%(10/10)在出生后的前6个月内循环中有供体细胞,移植sca+细胞的小鼠中有44%(4/9)出现这种情况(P=0.031)。sca+组小鼠平均在9.1±0.2天排斥供体皮肤移植,而c-kit+组小鼠平均在15.1±0.7天排斥供体皮肤移植(P=0.001)。移植组与未移植对照组之间的差异也具有统计学意义(P<0.05)。所有移植sca+/lin-细胞的小鼠在所有效应细胞与靶细胞比例下对供体细胞的反应均比对第三方细胞的反应更强(P=0.002)。sca+组和c-kit+组对供体同种异体抗原反应的差异具有统计学意义(P=0.003)。细胞因子定量分析表明,所有组中TH1细胞因子的释放均高于TH2细胞因子,与c-kit+小鼠相比,sca+小鼠对供体细胞的反应更高(P=0.031)。
这些结果表明,在子宫内移植sca+/lin-和c-kit+/lin-细胞的小鼠中,嵌合体水平和耐受性较低。移植sca+细胞的小鼠皮肤移植排斥加速以及具有持续性微嵌合体的小鼠体外免疫反应增强,支持了子宫内对供体细胞进行主动免疫的可能性。